- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Aligos Therapeutics Inc (ALGS)
Aligos Therapeutics Inc stock price live, this page displays NASDAQ ALGS stock exchange data. View the ALGS premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Aligos Therapeutics Inc real time stock price chart below.
What Is the Aligos Therapeutics Inc Stock Price Today?
The Aligos Therapeutics Inc stock price today is 7.470.
What Is the Stock Symbol for Aligos Therapeutics Inc?
The stock ticker symbol for Aligos Therapeutics Inc is ALGS.
Is ALGS the Same as $ALGS?
$ALGS is a common way to refer to the Aligos Therapeutics Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Aligos Therapeutics Inc Trade On?
Aligos Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Aligos Therapeutics Inc a Good Stock to Buy?
Determining whether Aligos Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Aligos Therapeutics Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ALGS quote. (ISIN: US01626L2043)
What Is the Aligos Therapeutics Inc Stock Price Today?
The Aligos Therapeutics Inc stock price today is 7.470.
What Is the Stock Symbol for Aligos Therapeutics Inc?
The stock ticker symbol for Aligos Therapeutics Inc is ALGS.
Is ALGS the Same as $ALGS?
$ALGS is a common way to refer to the Aligos Therapeutics Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Aligos Therapeutics Inc Trade On?
Aligos Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Aligos Therapeutics Inc a Good Stock to Buy?
Determining whether Aligos Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Aligos Therapeutics Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ALGS quote. (ISIN: US01626L2043)
7.480
-1.260(-14.42%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.310
8.200
52 wk Range
4.200
13.689
Unusual trading volume
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.3108.200
52 wk Range
4.20013.689
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ALGS Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
65.800
Upside
+779.68%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapeutics to address unmet medical needs in liver and viral diseases. Its drug candidate, ALG-055009, a small molecule THR-ß agonist that is in the Phase 2a clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis and obesity. The company also develops pevifoscorvir sodium, a capsid assembly modulator, which is in Phase 2 B clinical trial; and ALG-097558, a small molecule ritonavir-free pan-coronavirus protease inhibitor which has completed a Phase 1 clinical trial for the treatment of coronavirus. The company has entered into license and research collaboration agreement with Emory University; and Katholieke Universiteit Leuven. Aligos Therapeutics, Inc. was incorporated in 2018 and is headquartered in South San Francisco, California.
Compare ALGS to Peers and Sector
Metrics to compare | ALGS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipALGSPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.2x | −9.1x | −0.5x | |
PEG Ratio | −0.03 | 0.08 | 0.00 | |
Price / Book | 1.0x | 4.2x | 2.6x | |
Price / LTM Sales | 24.7x | 18.7x | 3.2x | |
Upside (Analyst Target) | - | 60.1% | 47.6% | |
Fair Value Upside | Unlock | −8.8% | 6.1% | Unlock |
Analyst Ratings
5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 65.800
(+779.68% Upside)
Earnings
Latest Release
Mar 05, 2026
EPS / Forecast
-1.92 / -0.26
Revenue / Forecast
169K / --
People Also Watch
FAQ
What Is the Aligos (ALGS) Stock Price Today?
The Aligos stock price today is 7.480 USD.
What Stock Exchange Does Aligos Trade On?
Aligos is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Aligos?
The stock symbol for Aligos is "ALGS."
What Is the Aligos Market Cap?
As of today, Aligos market cap is 45.850M USD.
What Is Aligos's Earnings Per Share (TTM)?
The Aligos EPS (TTM) is -2.450.
From a Technical Analysis Perspective, Is ALGS a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Aligos Stock Split?
Aligos has split 1 times.
How Many Employees Does Aligos Have?
Aligos has 82 employees.
What is the current trading status of Aligos (ALGS)?
As of Apr 15, 2026, Aligos (ALGS) is trading at a price of 7.480 USD, with a previous close of 8.740 USD. The stock has fluctuated within a day range of 7.310 USD to 8.200 USD, while its 52-week range spans from 4.200 USD to 13.689 USD.
What Is Aligos (ALGS) Price Target According to Analysts?
The average 12-month price target for Aligos is 65.800 USD, with a high estimate of 175 USD and a low estimate of 20 USD. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +779.68% Upside potential.
What Is the ALGS Premarket Price?
ALGS's last pre-market stock price is 7.540 USD. The pre-market share volume is 5,710.000, and the stock has decreased by -1.200, or -13.730%.
What Is the ALGS After Hours Price?
ALGS's last after hours stock price is 7.820 USD, the stock has decreased by -0.920, or -10.530%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.